EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein

Yixuan Li iD, Liuxiong Luo, Lenart Senicar, Rica Asrosa, Burcu Kizilates, Kaizhong Xing, Elias Torres, Lizhou Xu, Danyang Li, Neil Graham, Amanda Heslegrave, Henrik Zetterberg und 2 weitere

Advanced Healthcare Materials · 2024-12 · 13 (30)

DOI: 10.1002/adhm.202401966 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.09.2024. Verfasst von Yixuan Li und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Materials Discovery, Department of Chemistry, University College London, London, WC1E 7JE, UK. Hauptthemen laut MEDLINE: Glial Fibrillary Acidic Protein, Graphite, Electrochemical Techniques, Molecular Imprinting. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College London, Swedish Research Council, European Union's Horizon Europe research and innovation programme.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate assessment of neurological disease through monitoring of biomarkers has been made possible using the antibody‐based assays. But these assays suffer from expensive development of antibody probes, reliance on complicated equipments, and high maintenance costs. Here, using the novel reduced graphene oxide/polydopamine‐molecularly imprinted polymer (rGO/PDA‐MIP) as the probe layer, a robust electrochemical sensing platform is demonstrated for the ultrasensitive detection of glial fibrillary acidic protein (GFAP), a biomarker for a range of neurological diseases. A miniaturized integrated circuit readout system is developed to interface with the electrochemical sensor, which empowers it with the potential to be used as a point‐of‐care (POC) diagnostic tool in primary clinical settings. This innovative platform demonstrated good sensitivity, selectivity, and stability, with imprinting factor evaluated as 2.8. A record low limit‐of‐detection (LoD) is down to 754.5 ag mL −1 , with a wide dynamic range from 1 to 10 6 fg mL −1 . The sensing platform is validated through the analysis of GFAP in clinical plasma samples, yielding a recovery rate range of 81.6–108.8% compared to Single Molecule Array (Simoa). This cost‐effective and user‐friendly sensing platform holds the potential to be deployed in primary and resource‐limited clinical settings for the assessment of neurological diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glial Fibrillary Acidic ProteinGraphiteElectrochemical TechniquesMolecular ImprintingPoint-of-Care SystemsPolymersLimit of DetectionHumansMolecularly Imprinted PolymersBiosensing TechniquesBiomarkersIndoles

Stichwörter der Autor:innen

glial fibrillary acidic proteinmolecularly imprinted polymerneurological disease monitoringpoint‐of‐care electrochemical sensorreduced graphene oxide

Substanzen

Glial Fibrillary Acidic ProteinGraphitePolymersgraphene oxidepolydopamineMolecularly Imprinted PolymersBiomarkersIndoles

Autor:innen und Institutionen

  • Institute for Materials Discovery, Department of Chemistry, University College London, London, WC1E 7JE, UK.
  • School of Materials Science and Engineering, Central South University, Changsha, 410083, P. R. China.
  • Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, UK.
  • Graphenea Semiconductor, Paseo Mikeletegi 83, San Sebastián, 20009, Spain.
  • College of Biosystems Engineering and Food Science, Zhejiang University, Hangzhou, 310058, China.
  • ZJU-Hangzhou Global Scientific and Technological Innovation Center, Zhejiang University, Hangzhou, 311215, P. R. China.

ORCID-Profile: Yixuan Li, Bing Li

Förderung

  • University College London
  • Swedish Research Council
  • European Union's Horizon Europe research and innovation programme
  • Swedish State Support for Clinical Research
  • National Institute for Health and Care Research
  • Familjen Erling-Perssons Stiftelse
  • Olav Thon Stiftelsen
  • Cure Alzheimer's Fund

Zitieren

APA

Li, Y., Luo, L., Senicar, L., Asrosa, R., Kizilates, B., Xing, K., Torres, E., Xu, L., Li, D., Graham, N., Heslegrave, A., Zetterberg, H., Sharp, D. J., & Li, B. (2024). An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein. Advanced Healthcare Materials, 13(30). https://doi.org/10.1002/adhm.202401966

Vancouver

Li Y, Luo L, Senicar L, Asrosa R, Kizilates B, Xing K, et al. An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein. Advanced Healthcare Materials. 2024;13(30). doi:10.1002/adhm.202401966

BibTeX
@article{Li2024,
  author = {Li, Yixuan and Luo, Liuxiong and Senicar, Lenart and Asrosa, Rica and Kizilates, Burcu and Xing, Kaizhong and Torres, Elias and Xu, Lizhou and Li, Danyang and Graham, Neil and Heslegrave, Amanda and Zetterberg, Henrik and Sharp, David J and Li, Bing},
  title = {An Ultrasensitive Molecularly Imprinted Point‐Of‐Care Electrochemical Sensor for Detection of Glial Fibrillary Acidic Protein},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  volume = {13},
  number = {30},
  doi = {10.1002/adhm.202401966}
}
Kostenlos starten →